Commonwealth Equity Services’s Dare Bioscience DARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $40K | Buy |
16,735
+50
| +0.3% | +$120 | ﹤0.01% | 4177 |
|
|
2025
Q1 | $48K | Buy |
16,685
+50
| +0.3% | +$144 | ﹤0.01% | 4066 |
|
|
2024
Q4 | $52K | Sell |
16,635
-851
| -5% | -$2.66K | ﹤0.01% | 3980 |
|
|
2024
Q3 | $57K | Buy |
17,486
+13,659
| +357% | +$44.5K | ﹤0.01% | 3920 |
|
|
2024
Q2 | $15K | Hold |
3,827
| – | – | ﹤0.01% | 3980 |
|
|
2024
Q1 | $23K | Buy |
3,827
+1,108
| +41% | +$6.66K | ﹤0.01% | 3951 |
|
|
2023
Q4 | $10K | Sell |
2,719
-1,392
| -34% | -$5.12K | ﹤0.01% | 3858 |
|
|
2023
Q3 | $23K | Sell |
4,111
-21
| -0.5% | -$117 | ﹤0.01% | 3723 |
|
|
2023
Q2 | $45K | Sell |
4,132
-250
| -6% | -$2.72K | ﹤0.01% | 3671 |
|
|
2023
Q1 | $54 | Buy |
4,382
+750
| +21% | +$9 | ﹤0.01% | 3572 |
|
|
2022
Q4 | $36K | Hold |
3,632
| – | – | ﹤0.01% | 3542 |
|
|
2022
Q3 | $43K | Hold |
3,632
| – | – | ﹤0.01% | 3502 |
|
|
2022
Q2 | $53K | Buy |
3,632
+1,330
| +58% | +$19.4K | ﹤0.01% | 3475 |
|
|
2022
Q1 | $41K | Sell |
2,302
-313
| -12% | -$5.58K | ﹤0.01% | 3602 |
|
|
2021
Q4 | $62K | Buy |
2,615
+459
| +21% | +$10.9K | ﹤0.01% | 3510 |
|
|
2021
Q3 | $43K | Hold |
2,156
| – | – | ﹤0.01% | 3507 |
|
|
2021
Q2 | $48K | Buy |
2,156
+771
| +56% | +$17.2K | ﹤0.01% | 3464 |
|
|
2021
Q1 | $28K | Buy |
+1,385
| New | +$28K | ﹤0.01% | 3365 |
|
|
2016
Q4 | – | Sell |
-131
| Closed | -$16K | – | 2326 |
|
|
2016
Q3 | $16K | Hold |
131
| – | – | ﹤0.01% | 2226 |
|
|
2016
Q2 | $33K | Sell |
131
-42
| -24% | -$10.6K | ﹤0.01% | 2180 |
|
|
2016
Q1 | $56K | Hold |
173
| – | – | ﹤0.01% | 2118 |
|
|
2015
Q4 | $58K | Hold |
173
| – | – | ﹤0.01% | 2088 |
|
|
2015
Q3 | $76K | Buy |
+173
| New | +$76K | ﹤0.01% | 2014 |
|